BACKGROUND: South Africa has a large burden of rifampicin-resistant tuberculosis (RR-TB), with 18,734 patients diagnosed in 2014. The number of diagnosed patients has increased substantially with the introduction of the Xpert MTB/RIF test, used for tuberculosis (TB) diagnosis for all patients with presumptive TB. Routine aggregate data suggest a large treatment gap (pre-treatment loss to follow-up) between the numbers of patients with laboratory-confirmed RR-TB and those reported to have started second-line treatment. We aimed to assess the impact of Xpert MTB/RIF implementation on the delay to treatment initiation and loss to follow-up before second-line treatment for RR-TB across South Africa. METHODS AND FINDINGS: A nationwide retrospect...
SETTING: In Zimbabwe, there are concerns about the management of tuberculosis (TB) patients with rif...
Background. The Xpert MTB/RIF test shortens the time to microbiological confirmation of pulmonary tu...
Background. The Xpert MTB/RIF test shortens the time to microbiological confirmation of pulmonary tu...
Background: South Africa has a large burden of rifampicin-resistant tuberculosis (RR-TB), with 18,7...
Background: South Africa has a large burden of rifampicin-resistant tuberculosis (RR-TB...
Background: South Africa has a large burden of rifampicin-resistant tuberculosis (RR-TB...
Background: South Africa has a large burden of rifampicin-resistant tuberculosis (RR-TB), with 18,7...
BACKGROUND : Early diagnosis and treatment of drug resistant tuberculosis are crucial in the control...
Background: There are significant delays in initiation of multidrug-resistant tuberculosis (MDR –TB)...
Background: There are significant delays in initiation of multidrug-resistant tuberculosis (MDR –TB)...
Abstract Background In 2011, South Africa improved its ability to test for rifampicin-resistant TB (...
CITATION: Mahwire, T. C., et al. 2019. Impact of Xpert MTB/RIF assay on multidrug-resistant tubercul...
Background. Xpert MTB/RIF assay rapidly diagnoses rifampicin resistance, enabling early initiation o...
Background. Xpert MTB/RIF assay rapidly diagnoses rifampicin resistance, enabling early initiation o...
Background. Xpert MTB/RIF assay rapidly diagnoses rifampicin resistance, enabling early initiation o...
SETTING: In Zimbabwe, there are concerns about the management of tuberculosis (TB) patients with rif...
Background. The Xpert MTB/RIF test shortens the time to microbiological confirmation of pulmonary tu...
Background. The Xpert MTB/RIF test shortens the time to microbiological confirmation of pulmonary tu...
Background: South Africa has a large burden of rifampicin-resistant tuberculosis (RR-TB), with 18,7...
Background: South Africa has a large burden of rifampicin-resistant tuberculosis (RR-TB...
Background: South Africa has a large burden of rifampicin-resistant tuberculosis (RR-TB...
Background: South Africa has a large burden of rifampicin-resistant tuberculosis (RR-TB), with 18,7...
BACKGROUND : Early diagnosis and treatment of drug resistant tuberculosis are crucial in the control...
Background: There are significant delays in initiation of multidrug-resistant tuberculosis (MDR –TB)...
Background: There are significant delays in initiation of multidrug-resistant tuberculosis (MDR –TB)...
Abstract Background In 2011, South Africa improved its ability to test for rifampicin-resistant TB (...
CITATION: Mahwire, T. C., et al. 2019. Impact of Xpert MTB/RIF assay on multidrug-resistant tubercul...
Background. Xpert MTB/RIF assay rapidly diagnoses rifampicin resistance, enabling early initiation o...
Background. Xpert MTB/RIF assay rapidly diagnoses rifampicin resistance, enabling early initiation o...
Background. Xpert MTB/RIF assay rapidly diagnoses rifampicin resistance, enabling early initiation o...
SETTING: In Zimbabwe, there are concerns about the management of tuberculosis (TB) patients with rif...
Background. The Xpert MTB/RIF test shortens the time to microbiological confirmation of pulmonary tu...
Background. The Xpert MTB/RIF test shortens the time to microbiological confirmation of pulmonary tu...